收藏切换
Analysis of drug resistance and gene mutations in clinical Mycobacterium tuberculosis isolates, Ganzi Prefecture, Sichuan, 2018-2025
收藏切换
Dong-li YAN1, Qi-jin TIAN1, Xiao HE2, Ming-hui ZHOU1, Yong-jun DUAN1, Lan XIA2, Feng-gang DUAN1, Shu ZHANG2
Modern Preventive Medicine | 2026, 53(12) : 2265 - 2271
Less
收藏切换
Modern Preventive Medicine | 2026, 53(12): 2265-2271
• Experimental Technology and Application •
Analysis of drug resistance and gene mutations in clinical Mycobacterium tuberculosis isolates, Ganzi Prefecture, Sichuan, 2018-2025
Full
Dong-li YAN1, Qi-jin TIAN1, Xiao HE2, Ming-hui ZHOU1, Yong-jun DUAN1, Lan XIA2, Feng-gang DUAN1, Shu ZHANG2
Affiliations
  • Ganzi Prefecture Center for Disease Control and Prevention, Ganzi Prefecture, Sichuan 626000, China
Published: 2026-06-25 doi: 10.20043/j.cnki.MPM.202602107
Outline
收藏切换
Objective

To analyse the rifampicin and isoniazid resistance patterns and mutation sites in 793 clinical isolates of Mycobacterium tuberculosis from Garze Tibetan Autonomous Prefecture, Sichuan Province, collected between September 2018 and August 2025, so as to provide scientific basis for local tuberculosis prevention and control.

Methods

DNA microarray gene chips were used to perform rapid molecular detection of rifampicin and isoniazid resistance genes in collected M. tuberculosis isolates. The drug resistance and mutation of resistance genes in the region were analyzed, and chi square analysis was used to compare the drug resistance of different genders, ages, and agricultural landscape areas.

Results

The overall resistance rate of 793 cases of Mycobacterium tuberculosis to rifampicin and isoniazid was 18.16%, with a rifampicin resistance rate of 12.99%, isoniazid resistance rate of 10.7%, and multidrug resistance rate of 5.55%. According to statistical analysis, there was no significant difference in drug resistance rates between patients of different genders. The overall drug resistance rate (21.67%), isoniazid resistance rate (14.28%), and multidrug resistance rate (6.90%) were highest in patients aged 0-<20, and the rifampicin resistance rate (14.56%) was highest in the 40-<60 age group. Differences in overall resistance, rifampicin resistance, isoniazid resistance and multidrug resistance between age groups were not statistically significant. Drug resistance rates were higher in semi-agricultural/semi-pastoral areas than in purely agricultural or pastoral areas. However, no statistically significant differences were observed between overall drug resistance and rifampicin resistance. A statistically significant difference was found between isoniazid resistance and multidrug resistance(χ2=9.089,13.680,P<0.05). The predominant rifampicin resistance mutation site was rpoB531(C->T) (33.01%), followed by 516(G->T) (25.24%) and 511(T->C) (18.45%). Isoniazid resistance was predominantly mediated by katG gene mutations (92.94%), comprising katG315(G->C) (84.71%) and katG315(G->A) (8.24%), while inhA gene mutations accounted for 8.24%. Multidrug resistance was predominantly mediated by rpoB(516(G->T) katG(315(G->C) mutations, accounting for 52.27%.

Conclusion

Rifampicin and isoniazid resistance in tuberculosis cases from Garze Tibetan Autonomous Prefecture is severe. Resistance is more pronounced in the 0-<20 age group compared to other age cohorts, and is more prevalent in semi-agricultural/semi-pastoral areas than in purely agricultural or pastoral regions. Resistance mutations predominantly involve high-level resistance sites for both rifampicin and isoniazid. The region requires enhanced tuberculosis drug resistance testing and detection, strengthened standardised treatment and management of patients, and reduced generation and transmission of drug-resistant tuberculosis, and pay special attention to tuberculosis drug resistance prevention and control among low-age groups and people living in semi-agricultural and semi-pastoral areas.

Mycobacterium tuberculosis  /  Microarray gene chip  /  Multidrug-resistant tuberculosis (MDR-TB)  /  Rifampicin resistance  /  Isoniazid resistance
严冬丽, 田七斤, 何潇, 周明辉, 段勇军, 夏岚, 段凤刚, 张书. 四川省甘孜州2018—2025年结核分枝杆菌临床分离株耐药及基因突变情况分析. 现代预防医学, 2026 , 53 (12) : 2265 -2271 . DOI: 10.20043/j.cnki.MPM.202602107
Dong-li YAN, Qi-jin TIAN, Xiao HE, Ming-hui ZHOU, Yong-jun DUAN, Lan XIA, Feng-gang DUAN, Shu ZHANG. Analysis of drug resistance and gene mutations in clinical Mycobacterium tuberculosis isolates, Ganzi Prefecture, Sichuan, 2018-2025[J]. Modern Preventive Medicine, 2026 , 53 (12) : 2265 -2271 . DOI: 10.20043/j.cnki.MPM.202602107
Year 2026 volume 53 Issue 12
154
75
Cite this Article
BibTeX
Article Info
doi: 10.20043/j.cnki.MPM.202602107
  • Receive Date:2026-02-09
  • Online Date:2026-09-28
  • Published:2026-06-25
Article Data
Affiliations
History
  • Received:2026-02-09
Funding
Affiliations
    Ganzi Prefecture Center for Disease Control and Prevention, Ganzi Prefecture, Sichuan 626000, China
References
Share
https://castjournals.cast.org.cn/joweb/xdyfyx/EN/10.20043/j.cnki.MPM.202602107
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT